Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Executive Summary

• Cannabix Technologies announced the commercial delivery of its Marijuana Breath Test (MBT) system to a leading industrial manufacturing client in Virginia, marking the first deployment of the product within the U.S. manufacturing sector.
• The MBT detects recent cannabis use via breath analysis within four hours of consumption, offering a non‑invasive alternative to traditional urine or saliva tests.
• The delivery underscores Cannabix’s strategy to expand into safety‑critical industries and highlights a growing market opportunity for recent‑use testing tools.

Key Details

• Client & Geography: Unnamed major industrial manufacturing company operating in Virginia; delivery executed through an authorized reseller.
• Product Delivered: Marijuana Breath Test (MBT) system, comprising the proprietary Breath Collection Unit (BCU) and Breath Cartridge technologies.
• Detection Capability: Detects delta‑9 THC in breath at concentrations > 5 pg/L within a four‑hour window post‑use, using LC‑MS laboratory analysis.
• Industry Rationale: Manufacturing environments face heightened safety risks from cannabis‑related impairment; traditional testing methods cannot differentiate recent use from historic exposure.
• Strategic Significance: First confirmed rollout of MBT in the industrial manufacturing sector, signaling broader applicability across high‑risk workplaces (e.g., production lines, robotics, welding).
• Market Outlook: Cannabix identifies industrial manufacturing as a “substantial near‑term market opportunity” due to skilled‑labor dependence, increased THC‑related incidents, insurance/compliance pressures, and demand for recent‑use testing.
• Partnerships: Ongoing strategic partnership with Omega Laboratories, Inc., an accredited forensic drug‑testing laboratory with 25+ years of experience.
• Forward‑Looking Statements: Management anticipates further commercial rollouts, increased customer adoption, recurring revenue streams, and potential scale‑up of manufacturing capacity.

Notable Quotes

“As industrial workplaces evolve and cannabis use becomes increasingly commonplace, manufacturers require tools that deliver fairness and scientific relevance,” said Rav Mlait, CEO of Cannabix Technologies Inc.
“Our early delivery of the MBT system to a major manufacturing client in Virginia demonstrates the growing interest for accurate, non‑invasive testing that focuses specifically on recent cannabis use.”